Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 137.76K | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -142.76K | -267.38K | 0.00 | 0.00 | 0.00 |
EBITDA | -9.54M | -5.66M | -1.60M | -1.18M | -1.23M |
Net Income | -9.55M | -5.86M | -2.04M | -1.40M | -1.21M |
Balance Sheet | |||||
Total Assets | 9.68M | 13.03M | 3.56M | 2.69M | 2.35M |
Cash, Cash Equivalents and Short-Term Investments | 6.99M | 9.72M | 66.53K | 558.57K | 547.81K |
Total Debt | 1.11M | 1.39M | 1.61M | 608.77K | 720.63K |
Total Liabilities | 2.44M | 2.61M | 3.94M | 1.31M | 1.15M |
Stockholders Equity | 7.24M | 10.42M | -384.32K | 1.37M | 1.20M |
Cash Flow | |||||
Free Cash Flow | -9.21M | -8.90M | -1.47M | -1.44M | -2.01M |
Operating Cash Flow | -8.92M | -8.51M | -1.18M | -1.26M | -1.59M |
Investing Cash Flow | -241.47K | -359.22K | -311.17K | -87.21K | -312.25K |
Financing Cash Flow | 15.99M | 18.52M | 1.00M | 1.36M | 2.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $36.05B | 6.66 | -10.10% | 1.86% | 8.68% | -8.81% | |
45 Neutral | $373.07K | ― | -89.21% | ― | -100.00% | 96.37% | |
45 Neutral | $3.55M | ― | -248.95% | ― | ― | 98.45% | |
35 Underperform | ― | ― | ― | ― | |||
30 Underperform | $2.94M | ― | -660.37% | ― | ― | 74.27% | |
29 Underperform | $11.26M | ― | -212.38% | ― | ― | 57.99% | |
27 Underperform | $3.45M | ― | -512.79% | ― | ― | 31.66% |
On February 17, 2025, eXoZymes Inc., a Nevada corporation, experienced significant leadership changes as Mr. Mohammad Hayat resigned from his roles as President, Chairman, and Board member. Subsequently, the Board appointed Mr. Edgardo Rayo as a new Board member and Mr. Christopher A. Marlett as the new Chairman.